Ultra-fractionated radiation therapy
Sponsors
University of Texas Southwestern Medical Center, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Fudan University
Conditions
Adenosquamous Carcinoma of CervixBreast CancerCervical CancerMetastasisMicrosatellite Stable Metastatic Colorectal CancerRadiotherapy Side EffectStage IV Cervical Cancer FIGO 2018
Phase 2
Personalized Ultra-fractionated Stereotactic Adaptive Radiotherapy for Metastatic Cervical Cancer
Active, not recruitingNCT05021237
Start: 2022-02-01End: 2028-08-31Updated: 2025-08-28
Ultra-hypofractioNated Adjuvant Radiotherapy ± sImultaneous Integrated Boost for Low-risk Breast Cancer Patients
RecruitingNCT05762900
Start: 2022-10-25End: 2030-10-25Target: 65Updated: 2023-03-10
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR ) Combined With Anti-PD1，Chemotherapy and Target Therapy for Metastatic Colorectal Cancer
RecruitingNCT06841159
Start: 2024-03-01End: 2028-03-01Target: 116Updated: 2025-02-24